No price history available.
Key financial summary
Financials in TRY| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | TRYm | 1,037 | 1,740 | 3,887 | 2,882 | 1,688 | 4,973 | N/A | N/A |
| Operating profit | TRYm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | TRYm | -41 | 155 | 1,096 | -1,507 | -1,311 | 123 | N/A | N/A |
| EPS reported | TRY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | TRY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | TRY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | TRY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | TRYm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | TRYm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | TRYm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | TRY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | TRY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in TRY| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | |||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | |||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | |||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Bagfas Bandirma Gubre Fabrikalari A.S. is a Turkish enterprise dedicated to the production and supply of agricultural fertilizers. Its extensive product range features various chemical fertilizers, such as ammonium nitrate, calcium ammonium nitrate, diammonium phosphate, AS, sulfur composite fertilizers, sulfur-zinc composite fertilizers, and sulfur trioxide zinc NPK compounds. The company also formulates specialized blends. Additionally, Bagfas manufactures and delivers phosphoric and sulfuric acids, alongside other unique industrial chemicals. Founded in 1968, this Istanbul-headquartered firm also conducts international sales.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Bagfas Bandirma Gubre Fabrikalari A.S. (BAGFS.IS)
No price history available.
Based on consensus from external analysts. Not Kvantra's opinion.
Bagfas Bandirma Gubre Fabrikalari A.S. is a Turkish enterprise dedicated to the production and supply of agricultural fertilizers. Its extensive product range features various chemical fertilizers, such as ammonium nitrate, calcium ammonium nitrate, diammonium phosphate, AS, sulfur composite fertilizers, sulfur-zinc composite fertilizers, and sulfur trioxide zinc NPK compounds. The company also formulates specialized blends. Additionally, Bagfas manufactures and delivers phosphoric and sulfuric acids, alongside other unique industrial chemicals. Founded in 1968, this Istanbul-headquartered firm also conducts international sales.